News
Swiss pharma giant Roche says its new antibiotic zosurabalpin will progress to phase 3 testing. It’s the first drug in its ...
Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...
A review in Biomolecules and Biomedicine sheds light on how microRNAs (miRNAs)—small regulatory RNA molecules—play a central ...
Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...
A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...
Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...
An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...
Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...
Special Report: Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives RECCE® 327 ...
aClinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland bDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, ...
According to a new study, researchers have developed a 3D-printed stent designed to treat urinary tract infections (UTIs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results